Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. - Kan, S; Elanko, N; Johnson, D; Cornejo-Roldan, L; Cook, J; Reich, E; Tomkins, S; Verloes, A; Twigg, SR; Rannan-Eliya, S; McDonald-McGinn, D; Zackai, E; et al. (American journal of human genetics, 2002)